Background: Treatment by immune checkpoint blockade (ICB) provides a remarkable survival benefit for multiple cancer types. However. disease aggravation occurs in a proportion of patients after the first couple of treatment cycles. Methods: RNA sequencing data was retrospectively collected. https://parisnaturalfoodes.shop/product-category/lactoferrin-250/